Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA - PubMed (original) (raw)
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
B Dawson-Hughes et al. Osteoporos Int. 2008 Apr.
Abstract
Application of the WHO fracture prediction algorithm in conjunction with an updated US economic analysis indicates that osteoporosis treatment is cost-effective in patients with fragility fractures or osteoporosis, in older individuals at average risk and in younger persons with additional clinical risk factors for fracture, supporting existing practice recommendations.
Introduction: The new WHO fracture prediction algorithm was combined with an updated economic analysis to evaluate existing NOF guidance for osteoporosis prevention and treatment.
Methods: The WHO fracture prediction algorithm was calibrated to the US population using national age-, sex- and race-specific death rates and age- and sex-specific hip fracture incidence rates from the largely white population of Olmsted County, MN. Fracture incidence for other races was estimated by ratios to white women and men. The WHO algorithm estimated the probability (%) of a hip fracture (or a major osteoporotic fracture) over 10 years, given specific age, gender, race and clinical profiles. The updated economic model suggested that osteoporosis treatment was cost-effective when the 10-year probability of hip fracture reached 3%.
Results: It is cost-effective to treat patients with a fragility fracture and those with osteoporosis by WHO criteria, as well as older individuals at average risk and osteopenic patients with additional risk factors. However, the estimated 10-year fracture probability was lower in men and nonwhite women compared to postmenopausal white women.
Conclusions: This analysis generally endorsed existing clinical practice recommendations, but specific treatment decisions must be individualized. An estimate of the patient's 10-year fracture risk should facilitate shared decision-making.
Similar articles
- Cost-effective osteoporosis treatment thresholds: the United States perspective.
Tosteson AN, Melton LJ 3rd, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, Lindsay RL; National Osteoporosis Foundation Guide Committee. Tosteson AN, et al. Osteoporos Int. 2008 Apr;19(4):437-47. doi: 10.1007/s00198-007-0550-6. Epub 2008 Feb 22. Osteoporos Int. 2008. PMID: 18292976 Free PMC article. - Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines.
Bolland MJ, Grey A. Bolland MJ, et al. J Clin Endocrinol Metab. 2010 Apr;95(4):1856-60. doi: 10.1210/jc.2009-2157. Epub 2010 Feb 10. J Clin Endocrinol Metab. 2010. PMID: 20147581 Clinical Trial. - Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. Hernlund E, et al. Arch Osteoporos. 2013;8(1):136. doi: 10.1007/s11657-013-0136-1. Epub 2013 Oct 11. Arch Osteoporos. 2013. PMID: 24113837 Free PMC article. Review. - Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES, Baim S, Nattiv A. Siris ES, et al. Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Postgrad Med. 2010. PMID: 20107292 Review. - Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A; National Osteoporosis Guideline Group. Kanis JA, et al. Osteoporos Int. 2008 Oct;19(10):1395-408. doi: 10.1007/s00198-008-0712-1. Epub 2008 Aug 28. Osteoporos Int. 2008. PMID: 18751937
Cited by
- The break in FRAX: Equity concerns in estimating fracture risk in racial and ethnic minorities.
Reid HW, Selvan B, Batch BC, Lee RH. Reid HW, et al. J Am Geriatr Soc. 2021 Sep;69(9):2692-2695. doi: 10.1111/jgs.17316. Epub 2021 Jun 14. J Am Geriatr Soc. 2021. PMID: 34124772 Free PMC article. No abstract available. - Falls and fractures in the elderly with sinus node disease: the impact of pacemaker implantation.
Krasniqi N, Segalada D, Lüscher TF, Lippuner K, Haegeli L, Steffel J, Wolber T, Brunckhorst C, Holzmeister J, Hürlimann D, Duru F. Krasniqi N, et al. Cardiol Res Pract. 2012;2012:498102. doi: 10.1155/2012/498102. Epub 2012 Oct 24. Cardiol Res Pract. 2012. PMID: 23150844 Free PMC article. - Assessment of individual fracture risk: FRAX and beyond.
van den Bergh JP, van Geel TA, Lems WF, Geusens PP. van den Bergh JP, et al. Curr Osteoporos Rep. 2010 Sep;8(3):131-7. doi: 10.1007/s11914-010-0022-3. Curr Osteoporos Rep. 2010. PMID: 20563901 Free PMC article. - Screening to prevent fragility fractures among adults 40 years and older in primary care: protocol for a systematic review.
Gates M, Pillay J, Thériault G, Limburg H, Grad R, Klarenbach S, Korownyk C, Reynolds D, Riva JJ, Thombs BD, Kline GA, Leslie WD, Courage S, Vandermeer B, Featherstone R, Hartling L. Gates M, et al. Syst Rev. 2019 Aug 23;8(1):216. doi: 10.1186/s13643-019-1094-5. Syst Rev. 2019. PMID: 31443711 Free PMC article. - Automated bone mineral density prediction and fracture risk assessment using plain radiographs via deep learning.
Hsieh CI, Zheng K, Lin C, Mei L, Lu L, Li W, Chen FP, Wang Y, Zhou X, Wang F, Xie G, Xiao J, Miao S, Kuo CF. Hsieh CI, et al. Nat Commun. 2021 Sep 16;12(1):5472. doi: 10.1038/s41467-021-25779-x. Nat Commun. 2021. PMID: 34531406 Free PMC article.
References
- Adv Data. 2004 Oct 27;(347):1-17 - PubMed
- JAMA. 2002 Oct 9;288(14):1723-7 - PubMed
- JAMA. 2004 Apr 14;291(14):1701-12 - PubMed
- Lancet. 2002 Jun 1;359(9321):1929-36 - PubMed
- J Womens Health (Larchmt). 2005 Mar;14(2):159-71 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical